A study has found that people who have been vaccinated against coronary heart disease have a lower risk of health problems. A study by the University of Chittagong Veterinary and Animal Sciences (Sivasu) found that 82.5 per cent of those infected did not have to go to hospital for treatment after being vaccinated. Although 17.5 percent of the infected patients were admitted to the hospital after receiving the vaccine, no serious health risks were observed among them.
A study of 200 patients with corona after vaccination found that more than 8 percent of them did not have respiratory problems. 92% of patients did not need oxygen.
Due to old age and co-morbidity, some patients have difficulty breathing and need oxygen. Only one patient died after taking the first dose of the vaccine.
Studies have shown that most of the infected people became infected at least 32 days after vaccination. Their average body temperature was 101 degrees. The highest and lowest levels of sex and age ranged from 99 degrees to 104 degrees, respectively.
A study conducted in Chittagong region on the health risks of corona sufferers taking the first dose of Oxford-AstraZeneca vaccine produced by the Serum Institute of India under the leadership of Vice Chancellor Professor Gautam Buddha Das of Chittagong Veterinary and Animal Sciences University. Professor Dr. was among others in the research team. Sharmin Chowdhury, Dr. Iftekhar Ahmed Rana, Dr. Trideep Das, Dr. Pranesh Dutt, Dr. Sirajul Islam and Dr. Tanvir Ahmad Nizami.
The study was conducted from February 8 to April 13. Those on whom the study was conducted received the first dose of the vaccine from February 8.
The most notable symptom of coronary heart disease is shortness of breath. Most patients die from these respiratory and lung infections. However, the study found that 18 of the coronaviruses had no respiratory problems. However, due to age differences, aging factors and various co-morbidities, only 6 percent of patients had to provide breathing and extra oxygen, the study found.
The primary symptoms of coronary heart disease are fever, sneezing and cough. The study found that 44.5% of males and 91% of females had no cough or sneezing after coronary heart disease in patients taking the first dose. At the same time, 57.5% of male and 55.5% of female patients did not notice any change in taste and smell respectively.
The positive side of the study is that only one in 200 infected patients needs to be admitted to the ICU after receiving the first dose of vaccine. However, the patient died six days later. The deceased had a kidney transplant two years ago.
Sivasu VC Professor Gautam Buddha Das, head of the research team, said the study showed that corona was infected after vaccination but the risk of death was reduced. Only one in 200 infected people died after taking the first dose of the vaccine. This rate is zero point five percent. The deceased had been suffering from kidney complications for a long time. In addition, he had various diseases. He needed an ICU after being infected. However, others who took the first dose of the vaccine are better.